Dry Eye Syndrome Treatment Market Will Hit At A CAGR Of 6.4% From 2017 To 2027

Global Market for Dry Eye Syndrome Treatment Embraces New Hyaluronic Acid Formulations


VALLEY COTTAGE, N.Y. , June 07, 2018 (GLOBE NEWSWIRE) -- Common forms of artificial tears are known for being quick-fix remedies to dry eye syndrome. Drops of artificial tears with CMC and HPMC formulations were a top-selling product in the global market for dry eye syndrome treatment. Now, new products formulated from derivations of hyaluronic acid are witnessing a soaring demand among dry eye syndrome patients from around the world. Future Market Insights’ latest study on the global dry eye syndrome treatment market predicts that developing products with hyaluronic acid formulations will be observed lucrative for the market’s overall expansion.

According to the study, the global market for dry eye syndrome treatment is anticipated to bring in over US$ 4,500 Mn revenues by the end of 2017. Growing preference of consumers towards preservative-free, single dose remedies on dry eye syndrome is expected to stimulate the market’s growth. The market is also expected to witness promising support from governments & private organisations through awareness campaigns and other initiatives in the field of ophthalmic care. Towards the end of 2027, the global market for dry eye syndrome treatment is predicted to expand robustly at 6.4% CAGR, roughly doubling the 2017 value estimations by reaching US$ 6,609.3 Mn.

Request a Sample Report with Table of Contents and Figures: https://www.futuremarketinsights.com/reports/sample/rep-gb-1215

Dry Eye Syndrome Treatment Market – Key Trends

Public service programs in developed economies such as the US are providing eye care through volunteering ophthalmologists. These service are free of costs, successfully drawing attention of masses. Participation of government health authorities in such eye care drives is expected to promote the market’s growth. Reduced average length of stay (AVLOS) of dry eye syndrome treatment is also driving their demand among ophthalmology labs. Increasing demand for preservative-free eye care products, harmonised data collection, and availability of advanced labs to treat dry syndrome are also observed as key trends in the global dry eye syndrome treatment market.

Forecast Highlights & Key Players

The report has profiled key players in the global market for dry eye syndrome treatment. A competitive landscape on global dry eye syndrome treatment market includes companies such as Allergan Plc., Novartis AG, Otsuka Pharmaceutical Co. Ltd., Shire Plc., Santen Pharmaceutical Co Ltd., Valent Pharmaceuticals, Akorn, Inc., Abbott Laboratories, Thea Pharmaceuticals Limited, OASIS Medical, Altaire Pharmaceuticals Inc., Boiron USA, Similasan Corporation, Scope Ophthalmics Ltd., Reckitt Benckiser Group PLC., Medicom Healthcare Ltd., FDC Limited, Lupin Limited, Jamjoom Pharmaceuticals Co., and Sentiss Pharma Private limited.

Dry Eye Syndrome Treatment Market Segmentation Product Type – Cyclosporin, Oral Corticosteroids, Artificial Tears, Punctal Plugs (Removable, Dissolvable), Omega Supplements, Others; Distribution Channel - Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies: https://www.futuremarketinsights.com/reports/dry-eye-syndrome-treatment-market

Key highlights of the report include:

North America and Western Europe will collectively dominate the market throughout the forecast period, however, the individual revenue share will incur a marginal decline towards the latter half of the forecast period

Due to rising pollution levels and proximity of industrial contamination, the demand for dry eye syndrome treatment will surge significantly in Asia-Pacific excluding Japan region, reflecting fastest value growth at a CAGR of 7.4%

In 2017 and beyond, cyclosporine will be observed as top-selling product on dry eye syndrome treatment, global sales of which will account for a vigorous revenue growth at 6.9% CAGR

More than 60% of global dry eye syndrome treatment market will be dominated by sales through retail pharmacies, making them the largest distribution channel in the market.

Our advisory services are aimed at helping you with specific, customized insights that are relevant to your specific challenges. Let us know about your challenges and our trusted advisors will connect with you: https://www.futuremarketinsights.com/askus/rep-gb-1215

More from FMI’s Healthcare, Pharmaceuticals & Medical Devices:

  • Surgical Scalpels Market Segmentation by Product - Disposable Surgical Scalpels, Reusable Surgical Scalpels (Scalpel Handles, Surgical Blades); Material - Stainless Steel, High Grade Carbon Steel, Others; End User - Hospitals, Clinics, Ambulatory Surgical Centres, Nursing Centres, Reference Laboratories: https://www.futuremarketinsights.com/reports/surgical-scalpel-market
  • Blood Warmer Devices Market Segmentation Product Type - Intravenous Warming System, Surface Warming System, Blood Warming Accessories; End User – Hospitals, Blood Banks, Home Care Settings, Other End Users; Application - Preoperative Care, Home Care, Acute Care, New Born Care, Other Applications: https://www.futuremarketinsights.com/reports/blood-warmer-devices-market

About Us

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights and an aerial view of the competitive framework and future market trends.

Browse More: Healthcare, Pharmaceuticals & Medical Devices

Contact Us

Mr. Sudip Saha
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
T (UK): + 44 (0) 20 7692 8790
Sales: sales@futuremarketinsights.com
Press Office: Press@futuremrketinsights.com
FMI Blog: http://www.fmiblog.com/
Website: www.futuremarketinsights.com